Answer
Periodic liver function tests are recommended during dacomitinib monohydrate (Vizimpro) treatment because increased transaminases and hepatotoxicity have been reported, and hepatic failure caused one death across the dacomitinib programme.
Sources for this answer
- Vizimpro 15mg film-coated tabletsPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked